期刊文献+

化疗药物对老年肿瘤患者的肾损伤 被引量:4

原文传递
导出
摘要 恶性肿瘤严重危害着人类的健康,随着我国人口的老龄化,老年肿瘤患者的比例逐年增加。张薇等报道,1997~1999年上海市区老年人恶性肿瘤新发病例占同期恶性肿瘤新发病例的64%,老年肺癌的标化率居第1位。李彤等对930例老年住院患者死亡原因分析调查显示,恶性肿瘤病死率最高。化疗作为治疗恶性肿瘤的一种重要方法,使很多老年肿瘤患者获益。
出处 《实用老年医学》 CAS 2014年第4期341-342,共2页 Practical Geriatrics
  • 相关文献

参考文献12

二级参考文献39

  • 1陈静,顾龙君,汤静燕,赵慧君,潘慈,薛惠良,陈静,王耀平.自身造血干细胞移植治疗儿童晚期恶性实体肿瘤[J].中华儿科杂志,2004,42(12):924-927. 被引量:4
  • 2项永兵,金凡,袁剑敏,孙璐,高玉堂.肿瘤登记资料统计分析的微机实用软件[J].中国慢性病预防与控制,1994,2(2):74-76. 被引量:5
  • 3郭晔,刘晔,许立功,郭慕依.氨磷汀对顺铂肾毒性损伤的保护作用及其机制的研究[J].中华肿瘤杂志,2006,28(1):8-12. 被引量:19
  • 4中本伸宏,刘荣有.抗肿瘤药导致的肝损害[J].日本医学介绍,2006,27(6):253-255. 被引量:5
  • 5Papadakou M,Xydakis E,Bonios M,et al.Adjuvant chemotherapy with cisplatin,etoposide, luorouracil and leucovorin for gastric carcinoma[J].J BUON,2006,11(3):285- 289.
  • 6Roth,AD,Fazio N,StuppR, et al.Docetaxel,cisplatin,and fluorouracil; docetaxel and cisplatin;and epirubiein,cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma:a randomized phase II trial of the Swiss Group for Clinical Cancer Research [J].J Clin Oncol,2007,25(22):3217-3223.
  • 7Lin SZ,Tong HF, You T, et al.Palliative gastrectomy and chemotherapy for stage IV gastric cancer[J].J Cancer Res Clin Oncol, 2008,134(2):187- 192.
  • 8Montero E,Abreu C,Tonino P, et al.Relationship between VEGF and p53 expression and tumor cell proliferation in human gas- trointestinal carcinomas[J].J Cancer Res Clin Oncol,2008,134(2): 193 - 201.
  • 9Maruta F,Ishizolae S,Hiraguri M,et al.A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer[J].Med Oncol,2007,24(1):71-75.
  • 10Chiesa MD, Buti S,Tomasello G,et al.A pilot phase II study of chemotherapy with oxaliplatin,folinic acid,5-fluorouracil and irinotecan in metastatic gastric cancer[J].Tumor,2007,93(3):244- 247.

共引文献159

同被引文献55

  • 1李俊霞,蒋云生.肾衰康清除中分子物质的临床研究[J].中国现代医学杂志,2005,15(21):3259-3261. 被引量:6
  • 2李俊霞,蒋云生.中分子物质在胃肠道的清除[J].福州总医院学报,2005,12(2):111-114. 被引量:1
  • 3程新,蒋云生.肾衰康联合爱西特治疗慢性肾衰的临床观察[J].实用预防医学,2006,13(5):1302-1302. 被引量:3
  • 4Perrone RD, Madias NE, Levy AS. Serum creatinine as an index of renal function : new insights into old concepts [ J ]. Clin Chem, 1992,38(10) :1933-1953.
  • 5Ahn MJ, Park CK, Choi JH, et al. Clinical significance of mi- crovessel density in multiple myeloma patients [ J ]. Korean Med Sci, 2001,16 ( 1 ) :45-50. DOI : 10. 3346/jkms. 2001.16.1. 45.
  • 6Merlini G, Baldini L, Broglia C, et al. Prognostic factors in symp- tomatic Waldenstrom' s macroglobulinemia [ J ]. Semin oncol, 2003,30(2) :211-215. DOI: 10. 1053/sonc. 2003. 50064.
  • 7Finney H, Newman D J, Price CP. Adult reference ranges for ser- um cystatin C, creatinine and predicted creatinine clearance[ J]. Ann Clin Biochem, 2000, 37 ( Pt 1 ) : 49-59. DOI: 10. 1258/ 0004563001901524.
  • 8Laterza OF, Price CP, Scott MG. Cystatin C: an improved estima- tor of glomerular filtration rate ? [ J]. Clin Chem, 2002,48 (5) :699-707.
  • 9Turk V, Stoka V, Vasiljeva O, et al. Cysteine cathepsins: from structure, function and regulation to new frontiers [ J ]. Biochim Biophys Acta, 2012,1824(1 ) :68-85. DOI: 10. 1016@ bbapap. 2011.10. 002.
  • 10Shi GP, Sukhova GK, Grubb A, et al. Cystatin C deficiency in human atherosclerosis and aortic aneurysms [ J ]. J Clin Invest, 1999,104(9) :1191-1197. DO1: 10. 1172/JCI7709.

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部